98 related articles for article (PubMed ID: 38517294)
1. T cell immune response within B-cell follicles.
Huang Q; Xu L; Ye L
Adv Immunol; 2019; 144():155-171. PubMed ID: 31699216
[TBL] [Abstract][Full Text] [Related]
2. Antibody-Suppressor CXCR5+CD8+ T Cells Are More Potent Regulators of Humoral Alloimmunity after Kidney Transplant in Mice Compared to CD4+ Regulatory T Cells.
Han JL; Zimmerer JM; Zeng Q; Chaudhari S; Satoskar A; Abdel-Rasoul M; Uwase H; Breuer CK; Bumgardner GL
J Immunol; 2024 May; 212(9):1504-1518. PubMed ID: 38517294
[TBL] [Abstract][Full Text] [Related]
3. mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.
Avila CL; Zimmerer JM; Elzein SM; Pham TA; Abdel-Rasoul M; Bumgardner GL
Transplantation; 2016 Sep; 100(9):1898-906. PubMed ID: 27362313
[TBL] [Abstract][Full Text] [Related]
4. Antibody-suppressor CD8+ T Cells Require CXCR5.
Zimmerer JM; Ringwald BA; Elzein SM; Avila CL; Warren RT; Abdel-Rasoul M; Bumgardner GL
Transplantation; 2019 Sep; 103(9):1809-1820. PubMed ID: 30830040
[TBL] [Abstract][Full Text] [Related]
5. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection.
Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
Front Immunol; 2018; 9():3039. PubMed ID: 30740108
[TBL] [Abstract][Full Text] [Related]
6. CXCR5 + CD8 + T Cell-mediated Suppression of Humoral Alloimmunity and AMR in Mice Is Optimized With mTOR and Impaired With Calcineurin Inhibition.
Han JL; Zimmerer JM; Zeng Q; Chaudhari SR; Hart M; Satoskar AA; Abdel-Rasoul M; Breuer CK; Bumgardner GL
Transplantation; 2024 Mar; 108(3):679-692. PubMed ID: 37872660
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T-cell therapy approaches.
McCallion O; Bilici M; Hester J; Issa F
Clin Exp Immunol; 2023 Mar; 211(2):96-107. PubMed ID: 35960852
[TBL] [Abstract][Full Text] [Related]
8. Antibody-suppressor CXCR5
Zimmerer JM; Han JL; Peterson CM; Zeng Q; Ringwald BA; Cassol C; Chaudhari S; Hart M; Hemminger J; Satoskar A; Abdel-Rasoul M; Wang JJ; Warren RT; Zhang ZJ; Breuer CK; Bumgardner GL
Am J Transplant; 2022 Jun; 22(6):1550-1563. PubMed ID: 35114045
[TBL] [Abstract][Full Text] [Related]
9. Invariant NKT Cells Promote the Development of Highly Cytotoxic Multipotent CXCR3
Zimmerer JM; Ringwald BA; Chaudhari SR; Han J; Peterson CM; Warren RT; Hart MM; Abdel-Rasoul M; Bumgardner GL
J Immunol; 2021 Dec; 207(12):3107-3121. PubMed ID: 34810223
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T Cells: Regulation of Identity and Function.
Grover P; Goel PN; Greene MI
Front Immunol; 2021; 12():750542. PubMed ID: 34675933
[TBL] [Abstract][Full Text] [Related]
11. Recipient myeloperoxidase-producing cells regulate antibody-mediated acute versus chronic kidney allograft rejection.
Miyairi S; Ueda D; Yagisawa T; Okada D; Keslar KS; Tanabe K; Dvorina N; Valujskikh A; Baldwin WM; Hazen SL; Fairchild RL
JCI Insight; 2021 Jul; 6(13):. PubMed ID: 34081629
[TBL] [Abstract][Full Text] [Related]
12. Cell therapy in transplantation: A comprehensive review of the current applications of cell therapy in transplant patients with the focus on Tregs, CAR Tregs, and Mesenchymal stem cells.
Mansourabadi AH; Mohamed Khosroshahi L; Noorbakhsh F; Amirzargar A
Int Immunopharmacol; 2021 Aug; 97():107669. PubMed ID: 33965760
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
